Impact of treatment of sleep apnoea on left ventricular function in congestive heart failure

Naughton, M T
October 1998
Thorax;Oct1998 Supp, Vol. 53, pS37
Academic Journal
No abstract available.


Related Articles

  • Sleep-disordered breathing and cardiovascular disease. Benjamin, J. Amit; Lewis, K.E. // Postgraduate Medical Journal;Jan2008, Vol. 84 Issue 987, p15 

    Sleep-disordered breathing (SDB) describes a group of disorders characterised by abnormalities in the frequency and/or depth of breathing while asleep. The most common type is the obstructive sleep apnoea/hypopnoea syndrome (OSAHS); it affects 2-4% of the adult population and is an independent...

  • Sleep disordered breathing and its treatment in congestive heart failure. Cormican, L. J.; Williams, A. // Heart;Oct2005, Vol. 91 Issue 10, p1265 

    Sleep disordered breathing (SDB) is a common problem with adverse cardiorespiratory, endocrinological, and endothelial effects. Recent studies demonstrate an even higher prevalence of SDB in congestive heart failure (CHF) than in a randomly selected population, with up to 40% and 11 % having...

  • Left Ventricular Diastolic Dysfunction as a Cause of Congestive Heart Failure. Bonow, Robert O.; Udelson, James E. // Annals of Internal Medicine;9/15/92, Vol. 117 Issue 6, p502 

    Presents a study that examined the mechanisms underlying left ventricular diastolic dysfunction in patients with congestive heart failure and normal systolic function. Clinical observations of congestive heart failure with normal systolic function; Factors contributing to altered left...

  • Complex sleep apnoea in congestive heart failure. Bitter, Thomas; Westerheide, Nina; Hossain, Mohammed Sajid; Lehmann, Roman; Prinz, Christian; Kleemeyer, Astrid; Horstkotte, Dieter; Oldenburg, Olaf // Thorax;May2011, Vol. 66 Issue 5, p402 

    BACKGROUND: Sleep disordered breathing is common and of prognostic significance in patients with congestive heart failure (CHF). Complex sleep apnoea (complexSA) is defined as the emergence of central sleep apnoea during continuous positive airway pressure (CPAP) treatment in patients with...

  • Coronary Thrombolysis—It's Worth the Risk. Teifenbrunn, Alan J.; Ludbrook, Philip A. // JAMA: Journal of the American Medical Association;4/14/89, Vol. 261 Issue 14, p2107 

    Focuses on the use of coronary thrombolysis for the treatment of acute evolving myocardial infarction. Improved left ventricular function; Decreased incidence and severity of congestive heart failure; Decreased incidence of late fatal arrhythmias.

  • Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Philippe, C.; Stoïca-Herman, M.; Drouot, X.; Raffestin, B.; Escourrou, P.; Hittinger, L.; Michel, P.-L.; Rouault, S.; D'Ortho, M.-P. // Heart;Mar2006, Vol. 92 Issue 3, p337 

    Objective: To compare compliance with and effectiveness of adaptive servoventilation (ASV) versus continuous positive airway pressure (CPAP) in patients with the central sleep apnoea syndrome (CSA) with Cheyne-Stokes respiration (CSR) and with congestive heart failure in terms of the...

  • HTN treatment prevents progression of LV hypertrophy, heart failure.  // Geriatrics;Aug96, Vol. 51 Issue 8, p65 

    Discusses the study `Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials,' by M. Moser and P.R. Hebert.

  • Levosimendan: A Viewpoint by Wilbert S. Aronow. Aronow, W.S. // Drugs;Mar2001, Vol. 61 Issue 5, p628 

    Comments on the effectivity of levosimendan for the treatment of patients with stable or decompensated congestive heart failure associated with abnormal left ventricular ejection fraction. Result of its clinical trial.

  • Imatinib.  // Reactions Weekly;5/15/2010, Issue 1301, p27 

    The article describes the case of a woman who developed congestive heart failure and left ventricular dysfunction while receiving treatment with imatinib for hypereosinophilic syndrome.

  • Central sleep apnoea syndrome in patients with chronic heart disease: a critical review of the current literature. Köhnlein, T.; Welte, T.; Tan, L. B.; Elliott, M. W. // Thorax;Jun2002, Vol. 57 Issue 6, p547 

    The prevalence, prognosis, clinical presentation, pathophysiology, diagnosis, and treatment of the central sleep apnoea syndrome (CSAS) are reviewed and its relationship with congestive heart failure (CHF) is discussed. Adequately powered trials are needed with survival and health status as end...


Read the Article


Sign out of this library

Other Topics